Koninklijke Philips | PHG - Cash And Equivalent


Koninklijke Philips reported EUR2.59B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Baxter International USD 2.15B 133M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Demant DKK 1.33B 188M Dec/2025
Dexcom USD 1.1B 13.2M Jun/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Fresenius EUR 2.06B 752M Mar/2026
General Electric Aerospace USD 9.35B 1.64B Jun/2026
Getinge SEK 2.05B 909M Jun/2026
Globus Medical USD 507.74M 53.2M Jun/2026
GN Store Nord DKK 865M 254M Mar/2026
Hitachi JPY 1.32T 44.54B Mar/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Koninklijke Philips EUR 2.59B 680M Mar/2026
Medtronic USD 1.95B 802M Mar/2026
Philips EUR 1.79B 803M Jun/2026
ResMed USD 1.47B 191.28M Jun/2026
Steris USD 482.3M 42.7M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026